These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21275038)

  • 21. Ethical issues in the relationships involving medicine and industry.
    Thomas PS; Tan KS; Yates DH
    Intern Med J; 2005 Dec; 35(12):732. PubMed ID: 16313554
    [No Abstract]   [Full Text] [Related]  

  • 22. In the dark: drug companies should be forced to publish all the results of clinical trials.
    Chalmers I
    New Sci; 2004 Mar 6-12; 181(2437):19. PubMed ID: 15139350
    [No Abstract]   [Full Text] [Related]  

  • 23. Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy?
    Ferris LE
    CMAJ; 2002 May; 166(10):1279-80. PubMed ID: 12041844
    [No Abstract]   [Full Text] [Related]  

  • 24. [ACCOMPLISH and the risks with company sponsored clinical trials].
    Furberg C
    Lakartidningen; 2009 Feb 11-17; 106(7):450. PubMed ID: 19350775
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical research and pharmaceutical industry. A relationship with advantages and disadvantages].
    ten Cate JW; Büller HR
    Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1572-6. PubMed ID: 10443284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reporting bias in industry-supported medication trials presented at the American Psychiatric Association meeting.
    Sen S; Prabhu M
    J Clin Psychopharmacol; 2012 Jun; 32(3):435. PubMed ID: 22561482
    [No Abstract]   [Full Text] [Related]  

  • 27. Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? No.
    Lawton V
    BMJ; 2009 Nov; 339():b4953. PubMed ID: 19946144
    [No Abstract]   [Full Text] [Related]  

  • 28. Commentary.
    Snapinn S
    Pharm Stat; 2011; 10(1):83-4. PubMed ID: 21275040
    [No Abstract]   [Full Text] [Related]  

  • 29. [Knowledge on feet of clay].
    Dahlqvist R
    Lakartidningen; 2008 May 7-13; 105(19):1405-6. PubMed ID: 18574980
    [No Abstract]   [Full Text] [Related]  

  • 30. Making available information from studies sponsored by the pharmaceutical industry: some current practices.
    O'Kelly M; Julious SA; Pyke S; Day S; Todd S; Seldrup J; Matcham J
    Pharm Stat; 2011; 10(1):60-9. PubMed ID: 21275036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Data availability for industry sponsored trials: what should medical journals require?
    Steinbrook R; Kassirer JP
    BMJ; 2010 Oct; 341():c5391. PubMed ID: 20940213
    [No Abstract]   [Full Text] [Related]  

  • 32. [The roles and responsibilities of the pharmaceutical industry].
    Dejgaard A; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Industry funded clinical trials: bias and quality.
    Del Parigi A
    Curr Med Res Opin; 2012 Jan; 28(1):23-5. PubMed ID: 22103762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes.
    Goldacre B
    BMJ; 2009 Nov; 339():b4949. PubMed ID: 19946143
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhancing transparency and efficiency in reporting industry-sponsored clinical research: report from the Medical Publishing Insights and Practices initiative.
    Clark J; Gonzalez J; Mansi B; Miller C; Mooney LA; Mosdell K; Richards D; Schreiweis M; Weigel A; Wager E
    Int J Clin Pract; 2010 Jul; 64(8):1028-33. PubMed ID: 20487047
    [No Abstract]   [Full Text] [Related]  

  • 36. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
    Lachin JM
    Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
    Newcombe JP; Kerridge IH
    Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Data transparency - an ethical imperative? Approaching the issues].
    Marckmann G; Strech D
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(3):207-13. PubMed ID: 21530911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood, sweat and tears.
    Magnus D
    Am J Bioeth; 2006; 6(3):1-2. PubMed ID: 16754438
    [No Abstract]   [Full Text] [Related]  

  • 40. How pharmaceutical industry funding affects trial outcomes: causal structures and responses.
    Sismondo S
    Soc Sci Med; 2008 May; 66(9):1909-14. PubMed ID: 18299169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.